An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
It is hypothesized that there are a number of tumor specific driver genes for metastatic prostate cancer. Here, the authors perform genome-wide CRISPRi screens and integrate these data with metastatic prostate cancer functional and clinical genomics data to show that KIF4A and WDR62 drive aggressive...
Guardado en:
Autores principales: | Rajdeep Das, Martin Sjöström, Raunak Shrestha, Christopher Yogodzinski, Emily A. Egusa, Lisa N. Chesner, William S. Chen, Jonathan Chou, Donna K. Dang, Jason T. Swinderman, Alex Ge, Junjie T. Hua, Shaheen Kabir, David A. Quigley, Eric J. Small, Alan Ashworth, Felix Y. Feng, Luke A. Gilbert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa65632946e846318209a6540b59b6ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metastatic and locally aggressive BCC: Current treatment options
por: Máire‐Caitlín Casey, et al.
Publicado: (2021) -
Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors
por: Qing Kay Li, et al.
Publicado: (2021) -
The “inherent vice” in the anti-angiogenic theory may cause the highly metastatic cancer to spread more aggressively
por: Denian Wang, et al.
Publicado: (2017) -
Mitochondrial mutations drive prostate cancer aggression
por: Julia F. Hopkins, et al.
Publicado: (2017) -
Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood
por: Hélène Péré, et al.
Publicado: (2021)